Australia's RHS Ltd. said shareholders approved the scheme of arrangement for PerkinElmer Inc.'s purchase of the company.
Under the scheme, Waltham, Mass.-based PerkinElmer will acquire 89,920,483 outstanding RHS shares.
The scheme is scheduled to be implemented June 14, following approval by the Federal Court of Australia.
RHS develops and markets biotechnology technologies.
